Anualidad
type: Class

Event
type: Class

Entity
type: Class

Conference
type: Class

Process
type: Class

Occurrent
type: Class

2014
type: Class

RDF description of 9TH WORLD MEETING ON PHARMACEUTICS, BIOPHARMACEUTICS AND PHARMACEUTICAL TECHNOLOGY - http://research.umh.es/vivo/pub/congreso/108443
type: Document
rights: termsOfUse
date: 2026-08-31T17:40:13
publisher: 9TH WORLD MEETING ON PHARMACEUTICS, BIOPHARMACEUTICS AND PHARMACEUTICAL TECHNOLOGY

9TH WORLD MEETING ON PHARMACEUTICS, BIOPHARMACEUTICS AND PHARMACEUTICAL TECHNOLOGY
type: Thing
most specific type: 2014
type: Process
RO_0002234: Chitosan-based hydrogels for Camptothecin delivery in colon
type: Entity
RO_0002234: Semisynthesis, Cytotoxic Activity and Oral Availability of new lipophilic 9-substituted Camptothecin derivatives
RO_0002234: DRUG ABSORPTION MODIFICATIONS IN GIARDIASIS
RO_0002234: Dissolution assays for Telmisartan to predict in vivo behaviour
type: Anualidad
date time interval: 108443 date
RO_0001025: Lisbon
most specific type: Conference
type: 2014
type: Conference
type: Event
geographic focus: international
RO_0002234: Validation study of three cell models for intestinal permeability and its variability: Pre-experimental, experimental and post-experimental factors
type: Occurrent
RO_0002234: EXCIPIENT EFFECTS ON BIOEQUIVALENCE OF ZOLPIDEM FORMULATIONS.

Chitosan-based hydrogels for Camptothecin delivery in colon
type: Conference
RO_0002353: 9TH WORLD MEETING ON PHARMACEUTICS, BIOPHARMACEUTICS AND PHARMACEUTICAL TECHNOLOGY
type: Document
type: ConferencePoster
type: 2014
type: Anualidad
type: IAO_0000030
type: Entity
type: BFO_0000031
type: Thing
type: BFO_0000002

Semisynthesis, Cytotoxic Activity and Oral Availability of new lipophilic 9-substituted Camptothecin derivatives
type: 2014
type: Document
type: Anualidad
type: IAO_0000030
type: BFO_0000002
type: ConferencePoster
RO_0002353: 9TH WORLD MEETING ON PHARMACEUTICS, BIOPHARMACEUTICS AND PHARMACEUTICAL TECHNOLOGY
type: BFO_0000031
type: Thing
type: Conference
type: Entity

DRUG ABSORPTION MODIFICATIONS IN GIARDIASIS
type: BFO_0000002
type: Anualidad
type: IAO_0000030
type: Document
type: ConferencePoster
type: Thing
type: Conference
type: Entity
type: 2014
type: BFO_0000031
RO_0002353: 9TH WORLD MEETING ON PHARMACEUTICS, BIOPHARMACEUTICS AND PHARMACEUTICAL TECHNOLOGY

Dissolution assays for Telmisartan to predict in vivo behaviour
type: Thing
type: Entity
type: IAO_0000030
type: BFO_0000002
type: ConferencePoster
type: BFO_0000031
type: Anualidad
RO_0002353: 9TH WORLD MEETING ON PHARMACEUTICS, BIOPHARMACEUTICS AND PHARMACEUTICAL TECHNOLOGY
type: Conference
type: Document
type: 2014

Lisbon
type: BFO_0000141
type: Location
type: Entity
type: Thing
type: BFO_0000006
type: BFO_0000004
type: BFO_0000002
RO_0001015: 9TH WORLD MEETING ON PHARMACEUTICS, BIOPHARMACEUTICS AND PHARMACEUTICAL TECHNOLOGY

Validation study of three cell models for intestinal permeability and its variability: Pre-experimental, experimental and post-experimental factors
type: BFO_0000031
type: Thing
type: IAO_0000030
type: Anualidad
type: Document
type: Entity
RO_0002353: 9TH WORLD MEETING ON PHARMACEUTICS, BIOPHARMACEUTICS AND PHARMACEUTICAL TECHNOLOGY
type: Conference
type: BFO_0000002
type: ConferencePoster
type: 2014

EXCIPIENT EFFECTS ON BIOEQUIVALENCE OF ZOLPIDEM FORMULATIONS.
type: BFO_0000002
type: ConferencePoster
type: IAO_0000030
type: BFO_0000031
type: Anualidad
type: Conference
type: 2014
RO_0002353: 9TH WORLD MEETING ON PHARMACEUTICS, BIOPHARMACEUTICS AND PHARMACEUTICAL TECHNOLOGY
type: Document
type: Thing
type: Entity